- Home
- VALU vs SVRA Comparison
VALU vs SVRA Comparison
Compare VALU & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- SVRA
- Stock Information
- Founded
- VALU 1931
- SVRA N/A
- Country
- VALU United States
- SVRA United States
- Employees
- VALU N/A
- SVRA N/A
- Industry
- VALU Investment Managers
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- SVRA Health Care
- Exchange
- VALU Nasdaq
- SVRA Nasdaq
- Market Cap
- VALU 510.6M
- SVRA 540.6M
- IPO Year
- VALU N/A
- SVRA N/A
- Fundamental
- Price
- VALU $45.90
- SVRA $2.93
- Analyst Decision
- VALU
- SVRA Buy
- Analyst Count
- VALU 0
- SVRA 7
- Target Price
- VALU N/A
- SVRA $9.86
- AVG Volume (30 Days)
- VALU 6.8K
- SVRA 994.8K
- Earning Date
- VALU 03-14-2025
- SVRA 03-06-2025
- Dividend Yield
- VALU 2.61%
- SVRA N/A
- EPS Growth
- VALU 26.35
- SVRA N/A
- EPS
- VALU 2.36
- SVRA N/A
- Revenue
- VALU $35,859,000.00
- SVRA N/A
- Revenue This Year
- VALU N/A
- SVRA N/A
- Revenue Next Year
- VALU N/A
- SVRA N/A
- P/E Ratio
- VALU $19.45
- SVRA N/A
- Revenue Growth
- VALU N/A
- SVRA N/A
- 52 Week Low
- VALU $36.00
- SVRA $2.60
- 52 Week High
- VALU $57.68
- SVRA $5.70
- Technical
- Relative Strength Index (RSI)
- VALU 31.00
- SVRA 43.56
- Support Level
- VALU $48.00
- SVRA $2.60
- Resistance Level
- VALU $49.82
- SVRA $3.14
- Average True Range (ATR)
- VALU 1.20
- SVRA 0.17
- MACD
- VALU -0.69
- SVRA -0.00
- Stochastic Oscillator
- VALU 1.77
- SVRA 47.83
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.